Crown Bioscience Inc.
Crown Bioscience to Showcase Scientific Expertise at Cambridge UK Symposium: Preclinical Evaluation of Novel Immunotherapies
SAN DIEGO, March 09, 2018 (GLOBE NEWSWIRE) -- Crown Bioscience , a wholly-owned subsidiary of Crown Bioscience International (TWSE:6554) and a global drug discovery and development services company providing translational platforms to advance oncology, inflammation, cardiovascular and metabolic disease research, announces it will host its annual Cambridge UK symposium on Thursday, March 15th at The Cambridge Building, Babraham Research Campus.
The scientific symposium, entitled "Perspectives on Oncology Drug Discovery; Immuno-Oncology and the Next Generation", will bring together some of the most influential names in preclinical oncology drug discovery. Distinguished speakers from various multinational pharmaceutical and European biotech companies will present data describing how their latest research efforts provide innovative, unique solutions to advance immunotherapeutics and preclinical pharmacology evaluation.
"I look forward to welcoming the scientific community to our 4th annual Cambridge UK Symposium", said Dr. Sebastian Dempe, CrownBio's Executive Director UK and European business unit. "Immuno-oncology and its preclinical modeling has become a tremendously important focus in cancer research. This year's symposium promises to provide an excellent opportunity for networking and scientific discussions around the latest advances in immuno-oncology research."
Register to attend the symposium here, http://bit.ly/CrownBio_Cambridge18
About Crown Bioscience Inc.
Crown Bioscience is a global drug discovery and development solutions company providing translational platforms to advance oncology, inflammation and metabolic disease research. With an extensive portfolio of relevant models and predictive tools, Crown Bioscience enables clients to deliver superior clinical candidates.
Crown Bioscience Inc.
Information om Globenewswire
Følg pressemeddelelser fra Globenewswire
Skriv dig op her og modtag pressemeddelelser på mail. Indtast din mail, klik på abonner og følg instruktionerne i den udsendte mail.
Flere pressemeddelelser fra Globenewswire
CoinField23.7.2018 11:31 | pressemeddelelse
Canada's CoinField cryptocurrency exchange going international with commission-free trading app moonGO through a new partnership
Magna International Inc.19.7.2018 21:36 | pressemeddelelse
Second Quarter 2018 Results Conference Call
Crown Bioscience Inc.19.7.2018 15:05 | pressemeddelelse
CrownBio Supports Excellence in Translational Research with Grant Award that Funds Innovative PDX Model Development in Immuno-Oncology
ForgeRock, Inc.19.7.2018 10:03 | pressemeddelelse
ForgeRock Opens Up Open Banking
David Crosby18.7.2018 18:06 | pressemeddelelse
David Crosby Announces Intent to License His Name to the Cannabis Industry
Seaborn Networks18.7.2018 17:02 | pressemeddelelse
Telecom Argentina's landing station and backhaul are selected for ARBR submarine cable system between Argentina & Brazil
I vores nyhedsrum kan du læse alle vores pressemeddelelser, tilgå materiale i form af billeder og dokumenter, og finde vores kontaktoplysninger.Besøg vores nyhedsrum